Clinical trial
Eptifibatide and ST Segment Resolution Following Primary PCI
NCT00812435 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Eptifibatide and ST Segment Resolution Following Primary PCI
- Lead sponsor
- Medstar Health Research Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 31, 2007
- Completion date
- March 31, 2011
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.